Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryoablation and DC-CIK for Advanced Liver Cancer
NCT05622825Phase 2Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jan 2023
- Primary completion
- Dec 2024
- Modality
- Prophylactic Vaccines, Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
01
Overview
Phase 2, open-label trial of dendritic cell vaccine + cytokine-induced killer cells in liver cancer, sponsored by National Taiwan University Hospital. Primary endpoint: Tumor Image Assessment at 6 weeks. Status: unknown.
02
Drugs
dendritic cell vaccine + cytokine-induced killer cells
03
Conditions
liver cancer
Beyond the preview
Go deeper on NCT05622825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05622825.